Hosted on MSN
Master molecular shapes with VSEPR theory
VSEPR theory provides a practical way to predict the 3D shapes of molecules by focusing on how electron pairs repel each other. This model explains why atoms arrange in specific geometries, from ...
Researchers from BIFOLD and Google DeepMind have developed MD-ET, a transformer-based molecular dynamics model that omits traditional physics constraints like energy conservation and equivariance.
Researchers at The University of Manchester have created a physics‑informed machine‑learning model that can run molecular simulations for unprecedented lengths of time, even at temperatures as high as ...
The idea is there is the red hot glow to show the 'extreme' temperatures of our simulations, and some molecules with blurred motion effects to show that it is a simulation. The study, published in ...
To build a self-supervised magnetic resonance imaging (MRI) foundation model from routine clinical scans and to test whether it can support key glioma-related applications, including post-therapy ...
Abstract: Accurate prediction of drug molecular properties is crucial for precision drug discovery, which is closely related to precise disease diagnosis. Understanding the physicochemical properties, ...
Human perception for effective object tracking in a 2D video stream arises from the implicit use of prior 3D knowledge combined with semantic reasoning. In contrast, most generic object tracking (GOT) ...
As Organic Light-Emitting Diode (OLED) technology advances in applications such as high-end displays, medical devices, and VR/AR systems, the development of high-performance materials that improve ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...
This process is costly, time-consuming, and has a low success rate. KAIST researchers have developed an AI model that, using only information about the target protein, can design optimal drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results